ArticleOncology letters2025

Risks of haematological malignancies in patients treated for solid tumours associated with the use of pegylated granulocyte colony-stimulating factors: A single centre study since 2005.

Samuel Vokurka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.